[
    [
        {
            "time": "",
            "original_text": "又崩了！4万亿的板块受重挫！风向标彻底变了嗎？ 连续下跌",
            "features": {
                "keywords": [
                    "崩盘",
                    "重挫",
                    "风向标",
                    "连续下跌"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "又崩了！4万亿的板块受重挫！风向标彻底变了嗎？ 连续下跌",
                "Correlation": 8,
                "Sentiment": 9,
                "Importance": 7,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 10,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "又崩了！4万亿的板块早盘重挫，千亿市值龙头股带头下跌，年内白马股纷纷卧倒 连续下跌",
            "features": {
                "keywords": [
                    "崩盘",
                    "早盘重挫",
                    "龙头股",
                    "白马股",
                    "连续下跌"
                ],
                "sentiment_score": -0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "又崩了！4万亿的板块早盘重挫，千亿市值龙头股带头下跌，年内白马股纷纷卧倒 连续下跌",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "2020 | 医药大变革新时代淘汰赛下的战略选择：与偕行，因势而动",
            "features": {
                "keywords": [
                    "医药",
                    "大变革",
                    "淘汰赛",
                    "战略选择"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "2020 | 医药大变革新时代淘汰赛下的战略选择：与偕行，因势而动",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 7,
                "Time_Proximity": 4,
                "Headline_Structure": 7,
                "Source_Recency": 3
            }
        },
        {
            "time": "",
            "original_text": "医药股全线走低，恒瑞医药、长春高新双双跌超4%",
            "features": {
                "keywords": [
                    "医药股",
                    "全线走低",
                    "恒瑞医药",
                    "长春高新",
                    "跌超4%"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "医药股全线走低，恒瑞医药、长春高新双双跌超4%",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "医药行业2020年投资策略报告：大浪淘沙，沉者为金",
            "features": {
                "keywords": [
                    "医药行业",
                    "投资策略",
                    "大浪淘沙",
                    "沉者为金"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "医药行业2020年投资策略报告：大浪淘沙，沉者为金",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 5,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 4,
                "Headline_Structure": 7,
                "Source_Recency": 3
            }
        },
        {
            "time": "",
            "original_text": "【国盛医药张金洋团队】医药行业2020年度策略：与偕行，因势而动 ——医药大变革新时代淘汰赛下的战略选择",
            "features": {
                "keywords": [
                    "医药行业",
                    "年度策略",
                    "大变革",
                    "淘汰赛",
                    "战略选择"
                ],
                "sentiment_score": 0.65,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "【国盛医药张金洋团队】医药行业2020年度策略：与偕行，因势而动 ——医药大变革新时代淘汰赛下的战略选择",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 5,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 4,
                "Headline_Structure": 8,
                "Source_Recency": 3
            }
        }
    ]
]